141st APHA Annual Meeting and Exposition

Home Events & Meetings Annual Meeting Schedule & Program

Recorded Annual Meeting Presentations (RAMP) are now available for purchase.
Only $90 for presenters, $140 for registered attendees and $200 for non-attendees.

Online Program

295678
Innovate or Deteriorate: A New Approach for LHD Clinical Funding


Tuesday, November 5, 2013 : 8:30 a.m. - 8:50 a.m.

Michelle Thorne, RN, MSN, Calhoun County Public Health Department, Battle Creek, MI
     
In the past, the Local Health Department (LHD) have relied upon federal, state and local dollars to fund their mandated essential public health services. Over the years these dollars continue to dissolve leaving health departments the difficult task to determine what services will be provided and how. The future of clinical services provided by the LHD is in question with the impending Affordable Care Act. Will this mean an end to the Immunization and Sexually Transmitted Infection clinics or will it instead require a new approach to funding avenues?

Learning Areas:

Protection of the public in relation to communicable diseases including prevention or control
Provision of health care to the public
Public health or related nursing

Learning Objectives:
Name the primary concerns for billing insurances from the local health department perspective.

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have been a Registered Nurse for over 23 years with the last 13 years spent in Public Health and am currently the Personal Health Manager at a County Public Health Department. I have spoken on various health issues both nationally and internationally. I have been directly involved in the billing of LHD clinical services for over eight years and am passionate about working toward changes to ensure efficient and effective billing reimbursement for LHDs.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

Back to: 4009.0: Public health system transformation under the Affordable Care Act